珀光生物调制与特兰胺酸用于治疗黑色素瘤:双盲随机对照试验的协议
Thais Rodrigues Galache1, Marcelo Galache2, Michelle Mota Sena1
1Postgraduate Program in Biophotonics Applied to the Health Sciences, , Universidade Nove de Julho (UNINOVE), São Paulo, SP, Brazil.
BMJ open
|July 21, 2023
概括
这项研究研究珀光生物调制 (PBM) 作为一种新的疹治疗方法. 结果将确定PBM是否与脂质体中松酸一样有效降低瘤的严重程度.
科学领域:
- 皮肤病学 皮肤病学
- 照相医疗 (photomedicine) 是一种医学.
- 化品科学 化品科学
背景情况:
- 黑色素是一种常见的超色素障碍.
- 光生物调制 (PBM) 通过抑制氨酸酶和减少黑色素的作用,显示出治疗黑色素的潜力.
- 需要进行临床试验来验证PBM对黑色素瘤的疗效.
研究的目的:
- 评估珀光生物调制 (590nm) 在疹治疗中的疗效.
- 在一项随机对照试验中,比较珀PBM与脂质体甘酸.
- 评估PBM对瘤严重程度和生活质量的影响.
主要方法:
- 一个受控的,随机的,双盲的,非劣等性试验,涉及54名患有面部黑色素瘤的参与者.
- 参与者每周接受珀PBM或假PBM,每天进行局部治疗,持续12周.
- 使用梅拉斯马区域和严重性指数 (MASI),角膜测量,摄影记录和生活质量调查问卷来评估梅拉斯马的严重程度.
主要成果:
- 主要结局:梅拉斯马区域和严重性指数 (MASI) 得分变化.
- 二级结局:表皮色素,摄影评价和梅拉斯马生命质量调查问卷得分.
- 使用治疗意图和通用混合模型进行数据分析,统计显著性设置为α < 0.05.
结论:
- 这项研究旨在提供珀PBM作为治疗黑色素瘤的临床证据.
- 结果将比较PBM的有效性与标准治疗,脂质体中毒酸的有效性.
- 结果将通过出版物和会议演讲传播.
相关概念视频
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K